ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice
Diabetes leads to an elevated risk of stroke and worse functional outcome compared to the general population. We investigate whether L-4F, an economical ApoA-I mimetic peptide, reduces neurovascular and white-matter damage in db/db type-2 diabetic (T2DM) stroke mice. L-4F (16 mg/kg, subcutaneously a...
Main Authors: | Xiaohui Wang, Rongwen Li, Alex Zacharek, Julie Landschoot-Ward, Michael Chopp, Jieli Chen, Xu Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.01127/full |
Similar Items
-
Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice
by: Min Zhou, et al.
Published: (2022-04-01) -
Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia
by: Lauren Culmone, et al.
Published: (2022-05-01) -
HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia
by: Poornima Venkat, et al.
Published: (2020-08-01) -
Treatment of vascular dementia in female rats with AV-001, an Angiopoietin-1 mimetic peptide, improves cognitive function
by: Huanjia Gao, et al.
Published: (2024-07-01) -
Interpersonal Competence in Young Adulthood and Right Laterality in White Matter
by: De Pisapia, Nicola, et al.
Published: (2017)